Search results for: 'Global, Budgeting'

This study examines how global multiomics technologies are changing the way that cancer is treated, with a focus on new developments, strategic needs, and future directions. By facilitating thorough tumor characterization, early detection, patient stratification, and real-time monitoring, multiomics—an integrated analysis of genomics, transcriptomi...

Despite global economic and industry challenges, in vitro diagnostics (IVD) markets are growing robustly at double the rate of the global pharmaceutical industry. The global IVD market size was $47.30 billion in 2013; it is expected to reach $62.63 billion in 2017, at a compound annual growth rate of 7.3%. Because of stagnating mature markets, comp...

New technological advances in life science instrumentation and research tools include the enhancement of next-generation sequencing (NGS) technology, digital PCR, and a wide range of informatics, robotics, and automated solutions. These improve workflow, facilitate and automate tasks, and make better use of workspaces in every area of industry. ...

The global biopharma patient access market is undergoing a structural shift as specialty medicines make downstream commercialization more complex and strategically important. Patient access is no longer limited to reimbursement support or hub services; it is becoming a commercialization control layer spanning authorization, affordability, therapy i...

18 Apr 2022  |  North America  |  Market Research

Global Vaccine Growth Opportunities

Capability Expansion in Nucleic Acid-based Vaccines is Accelerating the Disruption in Vaccines Globally

Infographics

×

Frost & Sullivan provides an outlook for the global vaccine industry for 2022 and beyond, including emerging trends and growth opportunities. Innovation, which remains mainstream in vaccine development, is augmenting investments by emerging vaccine developers in designing novel technology platforms, especially for nucleic acid-based vaccines. Spurr...

The unprecedented US tariff measures introduced in 2025 have triggered a global trade conflict, resulting in sharp contractions of trade volumes, extensive supply chain disruptions, and a profound reconfiguration of international business practices. With US average tariff rates surging to their highest levels in nearly a century, governments and bu...

07 Mar 2023  |  Global  |  Technology Research

Global Gut Microbiome Growth Opportunities

Targeted Gut Microbiome Technologies to Drive Transformational Growth Across the Global Healthcare Landscape

Infographics

×

This study identifies and analyzes research initiatives focused on the development of gut microbiome therapeutics. Disruption of the gut microbiome causes a range of health issues, including gastrointestinal diseases, immuno-oncological diseases, and metabolic diseases. Over the last decade, gut microbiome therapeutics have largely relied on untarg...

05 Sep 2024  |  Global  |  Technology Research

R&D Investment Analysis of the Medtech Sector

Artificial Intelligence Integration and Medical Devices Miniaturization to Drive Transformational Growth

Infographics

×

Before the COVID-19 pandemic, medical technology (medtech) registered significant investment in R&D. However, the investment trend declined post-pandemic but is gradually picking up momentum. Top medtech companies invest about 7% to 8% of their total revenues toward the R&D of novel products or to enhance existing products. The key sources for medt...

The global life sciences industry is onto a rocking start with the surge in CEO confidence from US tax reforms, rollicking equity markets and strengthening the global economy. Healthcare digitization, democratization creating explosion in patient data, emergence of value-based reimbursement models, and healthcare consumerism shifting the risk from ...